Iovance Biotherapeutics (NASDAQ:IOVA) Price Target Lowered to $10.00 at Mizuho
Iovance Biotherapeutics (NASDAQ:IOVA – Get Free Report) had its price target decreased by investment analysts at Mizuho from $30.00 to $10.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage currently has an “outperform” rating on the biotechnology company’s stock. Mizuho’s target price indicates a potential upside of 458.66% from […]
More Stories
Israeli President Hands Opposition Candidate First Chance at Forming Government
By Melanie Sun Israeli President Isaac Herzog on Saturday night said he would hand opposition leader Gadi Eisenkot the first...
Trump Offers White House Press Secretary Job to UFC Chief Dana White
By Sylvia Xu President Donald Trump said on Saturday that he offered the White House press secretary job to Ultimate...
Cost of Living, AI Bubble Top Consumer Concerns in November: UMich
By Andrew Moran U.S. consumer sentiment rebounded this month, but concerns surrounding ongoing cost-of-living issues and a potential artificial intelligence...
Wendy’s Rejects $1.4 Billion Buyout Offer From Nelson Peltz-Led Group
By Bill Pan Wendy’s has rejected a $1.4 billion takeover offer from billionaire investor Nelson Peltz, saying the proposal “substantially...
Best Family Halloween Movies to Watch
Halloween movies for families is one of the most searched phrases before Halloween night every year. October is the perfect...
GOP Rep. Luna Wins Reelection to House District in Florida
By Zachary Stieber Rep. Anna Paulina Luna (R-Fla.) has won another term representing Florida in the U.S. House of Representatives....